SCI
TECH
Home
About
The Market
Technology
The Product
Contact Us
News
More
Phase 1 Clinical Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier:
NCT04234048
Connect with us